163 related articles for article (PubMed ID: 19131895)
1. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous HAART improves survival in children coinfected with HIV and TB.
Pensi T; Hemal A; Banerjee T
Trop Med Int Health; 2012 Jan; 17(1):52-8. PubMed ID: 21967134
[TBL] [Abstract][Full Text] [Related]
3. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
5. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
Girardi E; Palmieri F; Cingolani A; Ammassari A; Petrosillo N; Gillini L; Zinzi D; De Luca A; Antinori A; Ippolito G
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):326-31. PubMed ID: 11317073
[TBL] [Abstract][Full Text] [Related]
6. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.
Català L; Orcau A; García de Olalla P; Millet JP; Rodríguez-Mondragón A; Caylà JA;
Int J Tuberc Lung Dis; 2011 Feb; 15(2):263-9, i. PubMed ID: 21219692
[TBL] [Abstract][Full Text] [Related]
7. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
[TBL] [Abstract][Full Text] [Related]
8. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
[TBL] [Abstract][Full Text] [Related]
9. Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.
Zanoni BC; Phungula T; Zanoni HM; France H; Feeney ME
AIDS; 2011 Jan; 25(1):49-55. PubMed ID: 20935555
[TBL] [Abstract][Full Text] [Related]
10. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
[TBL] [Abstract][Full Text] [Related]
11. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
[TBL] [Abstract][Full Text] [Related]
12. Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.
Périssé AR; Smeaton L; Chen Y; La Rosa A; Walawander A; Nair A; Grinsztejn B; Santos B; Kanyama C; Hakim J; Nyirenda M; Kumarasamy N; Lalloo UG; Flanigan T; Campbell TB; Hughes MD;
PLoS One; 2013; 8(12):e83643. PubMed ID: 24391801
[TBL] [Abstract][Full Text] [Related]
13. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Gray DM; Zar H; Cotton M
Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.
Taarnhøj GA; Engsig FN; Ravn P; Johansen IS; Larsen CS; Røge B; Andersen AB; Obel N
BMC Pulm Med; 2011 May; 11():26. PubMed ID: 21605366
[TBL] [Abstract][Full Text] [Related]
15. Effect of pulmonary tuberculosis on mortality in patients receiving HAART.
Westreich D; MacPhail P; Van Rie A; Malope-Kgokong B; Ive P; Rubel D; Boulmé R; Eron J; Sanne I
AIDS; 2009 Mar; 23(6):707-15. PubMed ID: 19279444
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
17. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
[TBL] [Abstract][Full Text] [Related]
19. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Dheda K; Lampe FC; Johnson MA; Lipman MC
J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
[TBL] [Abstract][Full Text] [Related]
20. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
